Journalartikel
Autorenliste: Peteranderl, Christin; Herold, Susanne; Schmoldt, Carole
Jahr der Veröffentlichung: 2016
Seiten: 487-500
Zeitschrift: Seminars in Respiratory and Critical Care Medicine
Bandnummer: 37
Heftnummer: 4
ISSN: 1069-3424
eISSN: 1098-9048
Open Access Status: Green
DOI Link: https://doi.org/10.1055/s-0036-1584801
Verlag: Thieme Publishing / Georg Thieme Verlag
Abstract:
Seasonal and pandemic influenza are the two faces of respiratory infections caused by influenza viruses in humans. As seasonal influenza occurs on an annual basis, the circulating virus strains are closely monitored and a yearly updated vaccination is provided, especially to identified risk populations. Nonetheless, influenza virus infection may result in pneumonia and acute respiratory failure, frequently complicated by bacterial coinfection. Pandemics are, in contrary, unexpected rare events related to the emergence of a reassorted human-pathogenic influenza A virus (IAV) strains that often causes increased morbidity and spreads extremely rapidly in the immunologically naive human population, with huge clinical and economic impact. Accordingly, particular efforts are made to advance our knowledge on the disease biology and pathology and recent studies have brought new insights into IAV adaptation mechanisms to the human host, as well as into the key players in disease pathogenesis on the host side. Current antiviral strategies are only efficient at the early stages of the disease and are challenged by the genomic instability of the virus, highlighting the need for novel antiviral therapies targeting the pulmonary host response to improve viral clearance, reduce the risk of bacterial coinfection, and prevent or attenuate acute lung injury. This review article summarizes our current knowledge on the molecular basis of influenza infection and disease progression, the key players in pathogenesis driving severe disease and progression to lung failure, as well as available and envisioned prevention and treatment strategies against influenza virus infection.
Zitierstile
Harvard-Zitierstil: Peteranderl, C., Herold, S. and Schmoldt, C. (2016) Human Influenza Virus Infections, Seminars in Respiratory and Critical Care Medicine, 37(4), pp. 487-500. https://doi.org/10.1055/s-0036-1584801
APA-Zitierstil: Peteranderl, C., Herold, S., & Schmoldt, C. (2016). Human Influenza Virus Infections. Seminars in Respiratory and Critical Care Medicine. 37(4), 487-500. https://doi.org/10.1055/s-0036-1584801
Schlagwörter
acute lung injury; A H7N9 VIRUS; ANTIVIRAL THERAPY; ARDS; COLONY-STIMULATING FACTOR; HIGHLY PATHOGENIC H5N1; Lung injury; MESENCHYMAL STROMAL CELLS; N-linked glycosylation; pandemic; PANDEMIC H1N1 2009; seasonal; SIALIDASE FUSION PROTEIN; UNITED-STATES